The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube (212325)
ARTG Name
MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube
Product name
MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
brimonidine tartrate
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information